Colleen Jay to Humans
This is a "connection" page, showing publications Colleen Jay has written about Humans.
Connection Strength
0.362
-
Jay CL, Washburn WK, Rogers J, Harriman D, Heimbach J, Stratta RJ. Difference in Survival in Early Kidney after Liver Transplantation Compared with Simultaneous Liver-Kidney Transplantation: Evaluating the Potential of the "Safety Net". J Am Coll Surg. 2020 04; 230(4):463-473.
Score: 0.038
-
Jay CL, Cigarroa FG. Disparities in Live Donor Kidney Transplantation: Related to Poverty, Race, or Ethnicity? JAMA. 2018 01 02; 319(1):24-26.
Score: 0.033
-
Jay CL, Washburn K, Dean PG, Helmick RA, Pugh JA, Stegall MD. Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys. Transplantation. 2017 Apr; 101(4):867-872.
Score: 0.031
-
Jay C, Pugh J, Halff G, Abrahamian G, Cigarroa F, Washburn K. Graft quality matters: Survival after simultaneous liver-kidney transplant according to KDPI. Clin Transplant. 2017 05; 31(5).
Score: 0.031
-
Jay CL, Dean PG, Helmick RA, Stegall MD. Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress? Transplantation. 2016 05; 100(5):1120-7.
Score: 0.029
-
Jay CL, Skaro AI. Comparative effectiveness research in liver transplantation: crossing the cost and quality chasm. J Comp Eff Res. 2013 Jan; 2(1):7-9.
Score: 0.023
-
Jay CL, Skaro AI, Ladner DP, Wang E, Lyuksemburg V, Chang Y, Xu H, Talakokkla S, Parikh N, Holl JL, Hazen GB, Abecassis MM. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012 Jun; 18(6):630-40.
Score: 0.022
-
Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, Feinglass J, Holl JL, Abecassis M, Skaro AI. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol. 2011 Oct; 55(4):808-13.
Score: 0.020
-
Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, Abecassis MM, Skaro AI. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011 Feb; 253(2):259-64.
Score: 0.020
-
Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, Abecassis MM, Skaro AI. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg. 2010 Apr; 251(4):743-8.
Score: 0.019
-
Jay CL, Butt Z, Ladner DP, Skaro AI, Abecassis MM. A review of quality of life instruments used in liver transplantation. J Hepatol. 2009 Nov; 51(5):949-59.
Score: 0.018
-
Mena-Gutierrez AM, Reeves-Daniel AM, Jay CL, Freedman BI. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation. Transplantation. 2020 01; 104(1):27-32.
Score: 0.009
-
Rogers J, Farney AC, Orlando G, Harriman D, Reeves-Daniel A, Jay CL, Doares W, Kaczmorski S, Gautreaux MD, Stratta RJ. Dual Kidney Transplantation from Donors at the Extremes of Age. J Am Coll Surg. 2019 04; 228(4):690-705.
Score: 0.009
-
Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR. Building an Ideal Quality Metric for ESRD Health Care Delivery. Clin J Am Soc Nephrol. 2017 08 07; 12(8):1351-1356.
Score: 0.008
-
Skaro AI, Gallon LG, Lyuksemburg V, Jay CL, Zhao L, Ladner DP, VanWagner LB, De Wolf AM, Flaherty JD, Levitsky J, Abecassis MM, Gheorghiade M. The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med (Hagerstown). 2016 Dec; 17(12):875-885.
Score: 0.008
-
Chang Y, Gallon L, Shetty K, Chang Y, Jay C, Levitsky J, Ho B, Baker T, Ladner D, Friedewald J, Abecassis M, Hazen G, Skaro AI. Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Transplantation. 2015 Feb; 99(2):424-30.
Score: 0.007
-
Chang Y, Gallon L, Jay C, Shetty K, Ho B, Levitsky J, Baker T, Ladner D, Friedewald J, Abecassis M, Hazen G, Skaro AI. Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl. 2014 Sep; 20(9):1034-44.
Score: 0.006
-
Gordon EJ, Daud A, Caicedo JC, Cameron KA, Jay C, Fryer J, Beauvais N, Skaro A, Baker T. Informed consent and decision-making about adult-to-adult living donor liver transplantation: a systematic review of empirical research. Transplantation. 2011 Dec 27; 92(12):1285-96.
Score: 0.005
-
Baker TB, Jay CL, Fryer JP, Abecassis MM. Transplant renoportal vein conduit for complete mesenteric thrombosis: a case report. Am Surg. 2010 Sep; 76(9):1016-9.
Score: 0.005
-
Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, Martin JA, Feinglass JM, Preczewski LB, Abecassis MM. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009 Oct; 146(4):543-52; discussion 552-3.
Score: 0.005
-
Baker TB, Jay CL, Ladner DP, Preczewski LB, Clark L, Holl J, Abecassis MM. Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes. Surgery. 2009 Oct; 146(4):817-23; discussion 823-5.
Score: 0.005
-
Escobar MA, Jay CL, Brooks RM, West KW, Rescorla FJ, Molleston JP, Grosfeld JL. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006 Jan; 41(1):99-103; discussion 99-103.
Score: 0.004
-
Sandoval JA, Hoelz DJ, Woodruff HA, Powell RL, Jay CL, Grosfeld JL, Hickeyd RJ, Malkas LH. Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg. 2006 Jan; 41(1):245-51.
Score: 0.004
-
Escobar MA, Grosfeld JL, Burdick JJ, Powell RL, Jay CL, Wait AD, West KW, Billmire DF, Scherer LR, Engum SA, Rouse TM, Ladd AP, Rescorla FJ. Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes. Surgery. 2005 Oct; 138(4):560-71; discussion 571-2.
Score: 0.004